BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8787245)

  • 1. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.
    Rothstein JD
    Adv Neurol; 1995; 68():7-20; discussion 21-7. PubMed ID: 8787245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
    Rothstein JD
    Clin Neurosci; 1995-1996; 3(6):348-59. PubMed ID: 9021256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
    Rothstein JD; Martin LJ; Kuncl RW
    N Engl J Med; 1992 May; 326(22):1464-8. PubMed ID: 1349424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate/D-serine vs. inhibitory glycine/gamma-aminobutanoic acid (GABA).
    Sasabe J; Aiso S
    Chem Biodivers; 2010 Jun; 7(6):1479-90. PubMed ID: 20564566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
    Liu X; Rush T; Zapata J; Lobner D
    Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitotoxicity and amyotrophic lateral sclerosis.
    Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
    Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
    Anneser JM; Chahli C; Borasio GD
    Neuroscience; 2006 Sep; 141(4):1879-86. PubMed ID: 16820266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis.
    Plaitakis A
    Ann Neurol; 1990 Jul; 28(1):3-8. PubMed ID: 1973889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
    J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
    Plaitakis A; Constantakakis E; Smith J
    Ann Neurol; 1988 Sep; 24(3):446-9. PubMed ID: 2906529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein retention in the endoplasmic reticulum, blockade of programmed cell death and autophagy selectively occur in spinal cord motoneurons after glutamate receptor-mediated injury.
    Tarabal O; Calderó J; Casas C; Oppenheim RW; Esquerda JE
    Mol Cell Neurosci; 2005 Jun; 29(2):283-98. PubMed ID: 15911352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis.
    Zagami CJ; Beart PM; Wallis N; Nagley P; O'Shea RD
    Glia; 2009 Jan; 57(2):119-35. PubMed ID: 18661557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo.
    Tovar-Y-Romo LB; Santa-Cruz LD; Zepeda A; Tapia R
    Neurochem Int; 2009; 54(3-4):186-91. PubMed ID: 19100799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis.
    Sala G; Beretta S; Ceresa C; Mattavelli L; Zoia C; Tremolizzo L; Ferri A; Carrì MT; Ferrarese C
    Neurochem Int; 2005 Feb; 46(3):227-34. PubMed ID: 15670639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporospatial coupling of networked synaptic activation of AMPA-type glutamate receptor channels and calcium transients in cultured motoneurons.
    Jahn K; Grosskreutz J; Haastert K; Ziegler E; Schlesinger F; Grothe C; Dengler R; Bufler J
    Neuroscience; 2006 Nov; 142(4):1019-29. PubMed ID: 16949760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.